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Recombinant subviral particles (RSPs)
Virus trafﬁckingThe role of the membrane protein (prM/M) in ﬂavivirus life cycle remains unclear. Here, we identiﬁed a
cellular interactor to the 40-residue-long ectodomain of prM/M (ectoM) using a yeast two-hybrid screen
against a human cDNA library and GST pull-down assays. We showed that dynein light chain Tctex-1 interacts
with the ectoM of dengue 1–4, West Nile, and Japanese encephalitis ﬂaviviruses. No interaction was found
with yellow fever and tick-borne ﬂaviviruses. This interaction is highly speciﬁc since a single amino-acid
change in the ectoM abrogates the interaction with Tctex-1. To understand the role of this interaction,
silencing of Tctex-1 using siRNA was performed prior to infection. A signiﬁcant decrease in progeny
production was observed for dengue and West Nile viruses. Silencing Tctex-1 inhibited the production of
recombinant dengue subviral particles (RSPs). Thus Tctex-1 may play a role in late stages of viral replication
through its interaction with the membrane protein.es Flavivirus-Hôtes, Department
5724 Paris, CEDEX 15, France.
digon).
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Flaviviruses such as dengue (DENV), West Nile (WNV), Japanese
encephalitis (JEV) and yellow fever (YFV) viruses are arthropod-
borne pathogens (arboviruses) that are transmitted through the bite
of an infected mosquito and may cause serious human diseases
worldwide (Lindenbach et al., 2007). Outbreaks range from non-
speciﬁc febrile illness to severe hemorrhagic (DENV and YFV) or
encephalitic (JEV and WNV) syndromes. Arboviruses are becoming
important public and veterinary health problems in several parts of
the world, with numerous fatal cases reported. There is no available
vaccine or efﬁcient treatment against DENV and WNV.
Flaviviruses belong to the Flaviviridae family and are small
enveloped viruses that have a genome composed of a single-stranded
positive sense RNA of approximately 11 kb. The genome encodes a
polyprotein that is cleaved by host and viral proteases to generate
viral mature proteins, including 3 structural proteins (capsid (C),
membrane (M) and envelope (E) and 7 non-structural proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B and NS5)) (Lindenbach et al., 2007).
The membrane protein is synthesized as a precursor prM. The
cleavage of prM into the pr domain and M takes place in the trans-
golgian compartment (Chambers et al., 1990; Stadler et al., 1997;Wengler, 1989; Westaway and Goodman, 1987), just prior to the
production of mature virions, and this step is mandatory to generate
infectious particles (Chambers et al., 1990; Elshuber et al., 2003;
Lindenbach et al., 2007). The mature M protein thereby generated
consists of a 40 amino-acid long ectodomain (coined ectoM)
followed by 2 transmembrane domains (TMDs) (Chambers et al.,
1990).
Our understanding of the functions played by the membrane
protein remains quite evasive. Indeed, only a few studies described a
biological role for it. To date, it has been shown that prM protein acts
as a chaperone for the E protein folding (Konishi and Mason, 1993;
Lorenz et al., 2002) and that the pr domain remains associated to the
fusion loop of the E protein after cleavage of prM to prevent fusion
within the infected cell (Yu et al., 2009). We and others have shown
that ectoM of DENVMprotein is a potent inducer of apoptosis through
a mitochondrial-dependent pathway (Brabant et al., 2009; Catteau
et al., 2003a, 2003b). Very recently, it was shown that the C-terminal
helical domain of ectoM is involved in virus assembly and entry
(Hsieh et al., 2011).
In this study, we sought to ﬁnd cellular factors able to interact with
the membrane protein in order to better understand its role during
ﬂaviviral life cycle. By using the ectoM of several ﬂaviviruses as baits
in a series of yeast-two hybrid (Y2H) screens performed against a
human cDNA library, we identiﬁed Tctex-1, a dynein light chain
(DLC), as an interactor of the ectoM of DENV, WNV and JEV. This
cellular protein was previously involved in viral transport during
herpes simplex virus (Douglas et al., 2004) and poliovirus (Mueller
370 J.-B. Brault et al. / Virology 417 (2011) 369–378et al., 2002) infections. Using RNA interference against Tctex-1, we
demonstrate that the ectoM interaction with Tctex-1 plays a role in
the ﬂaviviral life cycle, most likely during the trafﬁcking of ﬂaviviral
particles within infected cells.
Results
Tctex-1 is a novel cellular protein interactor of DENV, JEV and WNV ectoM
In order to identify novel host factor(s) able to interact with the
ﬂavivirus membrane protein, we used the ectoM (the ectodomain of M
protein without TMDs) from the four serotypes of DENV (DENV1–4),
JEV,WNV, YFV and the live attenuated strain YFV17D as baits in a seriesFig. 1. Interaction of Tctex-1 with the ectoM of DENV1–4,WNV and JEV. (A) Y2H yeast strains
to express Gal4-AD fused to Tctex-1. Cells were plated on synthetic medium lacking histidine
HIS3 reporter gene. (B) HEK-293T cells were co-transfected with 2 μg of a plasmid encoding t
Tctex-1 fused to 3xFLAG. 48 h post-transfection, cells were harvested and GST pull-down exp
blot using antibodies directed against GST (panel A) and 3xFLAG (panel B). Presence of 3xFof yeast two-hybrid (Y2H) screens against a human spleen cDNA library.
Among host proteins captured with viral ectoMs as baits, only the DLC
Tctex-type 1 (Tctex-1) was identiﬁed in the different screens by
multiple virus species including DENV1, DENV2, DENV4, JEV, andWNV.
This interactionwas supported by only 1 to 10 yeast positive colonies in
each individual ectoM screen (data not shown), suggesting that Tctex-1
frequency in the human cDNA library is relatively low. This could
explain why Y2H screens performed with DENV-3, YFV, and YFV17D
failed to identify this interaction. To address this issue and further
validate these interactions, ectoM from all 8 viruses was systematically
retested for Tctex-1binding in theY2Hsystem(Fig. 1A). Yeast cellswere
co-transformed with each ectoM fused to the DNA binding domain of
Gal4 (DB-ectoM) and Tctex-1 fused to the transactivation domain ofexpressing Gal4-DB fused to ectoM proteins from tested ﬂavivirus were co-transformed
so that yeast growth is determined by ectoM interaction with Tctex-1 and activation of
he ectoM from tested ﬂavivirus fused to GST or GST alone and 2 μg of a plasmid encoding
eriments were performed. Expression of both fusion proteins was detected byWestern
LAG-Tctex-1 after pull-down was then detected (panel C).
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medium depleted for leucine and tryptophan where yeast growth
necessitates thepresenceofbothbait andpreyplasmids (Fig. 1A,His(+)
medium). On a synthetic medium that is also missing histidine, and
where yeast growth depends on ectoM interaction with Tctex-1, we
conﬁrmed Tctex-1 binding to ectoM fromWNVand JEV (Fig. 1A, His(−)
medium). In this pairwise setting, ectoMs from all DENV serotypes
including DENV-3 were also found to interact with Tctex-1. This
suggests that Tctex-1 interactionwithDENV-3was not identiﬁed inﬁrst
instance because of technical limitations, which probably relate to the
low frequencyof Tctex-1 in the library. On theother hand,weconﬁrmed
that ectoM of YFV and YFV17D do not interact with this cellular protein,
indicating that ectoM has distinct interaction properties among
ﬂaviviruses regarding Tctex-1. The same experiments were performed
using the WNV pr domain alone or fused to ectoM. Interestingly, the
pr-ectoM peptide also had the ability to interact with Tctex-1while it
was not the case for the pr domain alone, suggesting that ectoM is
sufﬁcient to promote the interaction with Tctex-1 but that it also
occurs in the presence of the pr domain (data not shown). To conﬁrm
the interaction of Tctex-1 with ectoM, we performed pull-down
experiments using plasmids encoding each of the ectoM sequences
used in the Y2H screens fused to glutathione-S-transferase (GST)
(Fig. 1B, panel A) and a plasmid encoding Tctex-1 fused to 3xFLAG
(Fig. 1B, panel B). We observed that in agreement with the Y2H
results DENV (1–4), WNV and JEV ectoM did interact with Tctex-1
(Fig. 1B, panel C, lanes 2, 3, 4, 5, 8 and 9 respectively). On the other
hand, after pulling down the GST-fused ectoM of YFV and YFV17D,
Tctex-1 signal was very weak compared to the other ectoM (Fig. 1,
panel C, lanes 6 and 7), conﬁrming our results obtained with the Y2H
screens. Even though the level of expression of GST-ectoM is variable
depending on the construct, it does not reﬂect on the ability of a given
ectoM to interact or not with Tctex-1 as it can be seen for GST-ectoM-
DENV2 compared to GST-ectoM YFV or YFV17D (Fig. 1, lane 3
compared to lanes 6 or 7). These results, obtained by using two
distinct techniques, show that the ectoM of the four DENV serotypes,
JEV and WNV are able to interact in vitro with the DLC Tctex-1 while
the ectoM of YFV or YFV17D is not.
The amino acid residue in position 5 within the ectoM of WNV is
essential for the interaction with Tctex-1
We then sought to identify the critical amino acids involved in the
molecular interaction of ﬂavivirus ectoM sequences with Tctex-1.
Alignment of amino acid sequences indicated that WNV (interacting
with Tctex-1) and YFV (not interacting with Tctex-1) ectoM displayed
identical aminoacids at positions 6, 7, 12, 19, 20, 27, 29, 31, 33, 35, 38–40
(Fig. 2A, blue boxes).Wehypothesized that some residues in YFV ectoM
that differed inWNV ectoM and in all the other ectoM sequences tested
could interferewith the capacity ofWNVectoM to interactwith Tctex-1.
The proximal region of ectoM that encompassed amino acids 1 to 8 was
targeted for mutation. Amino acid substitutions Ser to Ala at position 1,
Thr toAspatposition3,Gln to Pro atposition5, andGly toGlu atposition
8 altogether (Fig. 2A, red boxes) abrogated the interaction of WNV
ectoM with Tctex-1 by GST pull-down assay (data not shown). This
result suggested that the N-terminal region of WNV ectoM plays an
important role in its ability to interactwith Tctex-1.We then tested each
amino-acid substitution separately, and found that aGln toPromutation
at position 5 (Fig. 2A, *)was the only substitution that abolished Tctex-1
interactionwithWNVectoM (Fig. 2B, panel C, compare lane 3 to lane 2).
To further conﬁrm the importance of this amino acid residue in the
interaction with Tctex-1, we examined the capacity of ectoM from
Kyasanur Forest disease virus (KFDV), Omsk hemorrhagic fever virus
(OHFV), and tick-borne encephalitis virus (TBEV), all arboviruses
carrying a Pro at position 5 in their ectoM sequence, to interact with
Tctex-1 by GST pull-down assay and compared it with the ectoM of
Usutu virus (USUV), a closely related virus to WNV carrying a Glnresidue at this position (Fig. 2C). Remarkably, all ectoMs that contain a
Pro residue at position 5were unable to interact with Tctex-1, while the
only ectoM not carrying it was able to do so (Fig. 2D, panel C, lanes 2, 4
and 5 compared to lane 3). These results support the hypothesis that
amino acid at position 5 is a critical determinant of interaction of ectoM
with Tctex-1. Most importantly, this demonstrated that Tctex-1
interaction with the ectoM from a subset of ﬂavivirus is highly speciﬁc,
and can be disrupted by a single amino acid change.
Local concentration of Tctex-1 is found close to sites of DENV assembly
expressing prM protein
Subcellular localization of Tctex-1 and prM proteins was then
assessed in DENV infected-cells. For this purpose, HEK-293A cells
were infected with DENV for 24 h at a multiplicity of infection (MOI)
of 1 particle per cell. The subcellular localization of prM protein was
analyzed using 14E9 antibody, which is speciﬁc for DENV prM. Tctex-1
subcellular localization was analyzed using R5205 rabbit polyclonal
antiserum. The pattern of both staining was observed by indirect
immuno-ﬂuorescence using a confocal microscope in a sequential
acquisition mode (Fig. 3). Our results show that Tctex-1 concentrates
in the vicinity of prM-expressing structures in DENV-infected cells,
structures that might be sites of viral morphogenesis (see arrow-
heads, Fig. 3, upper panel). Magniﬁcation of infected cells (see framed
cells in bottom panel) conﬁrmed that the antibody directed against
prM protein stains a perinuclear region where Tctex-1 seems to be
largely expressed.
Tctex-1 is important for DENV and WNV progeny virus production
To determine whether Tctex-1 has a relevant role during infection,
we examined DENV, WNV and YFV progeny virus production from
human cells in which expression of Tctex-1 had been knocked-down
prior to infection. HepG2 cells were treated with a speciﬁc siRNA
directed against Tctex-1 mRNA (siRNA Tctex-1) or with a non-
targeting control (siRNA NT), and were infected 24 h post-treatment,
either with DENV or YFV at a MOI of 1 (Fig. 4, panels A and C). HEK-
293A cells were treated in the same way and infected with WNV at a
MOI of 1 (Fig. 4, panel B). Viral titers were measured by focus
immuno-detection assay (FIA) for DENV and WNV and by plaque
assay for YFV.
Whereas the difference in YFV titer was not signiﬁcant between
cells treated with NT or Tctex-1 siRNA (Fig. 4C), we observed a 65%
decrease in DENV titer in cells where Tctex-1 expression had been
knocked-down (Fig. 4A). WNV titer also showed a similar decrease of
about 70% (Fig. 4B). To control that silencing of Tctex-1 does not alter
early stages of infection, for example entry, cells were treated with
siRNA prior to infection and cells were stained for the E protein in an
immuno-ﬂuorescence assay 24 h post-infection. No signiﬁcant differ-
ence was observed in the proportion of infected cells when treated
with NT or Tctex-1 siRNA (data not shown). Taken together, these
results indicate that Tctex-1 is involved in DENV and WNV life cycle,
probably in late stages of the infection, whereas it does not seem to
participate in YFV life cycle. These results are consistent with the Y2H
and GST pull-down assays, as Tctex-1 showed the ability to interact
with DENV and WNV ectoM, while no interaction was observed with
YFV ectoM.
Tctex-1 participates in the production of DENV recombinant subviral
particles independently from microtubule cytoskeleton
Since dynein has already been involved in viral transport and is
also known to play a role in ER-to-Golgi transport, we hypothesized
that DENV or WNV hijack Tctex-1 to participate in the trafﬁcking of
viral particles along the secretory pathway. To test this hypothesis we
used a stable Hela cell line expressing DENV1 prM and E proteins
Fig. 2. The importance of amino acid 5 ofWNV ectoM for the interaction with Tctex-1. (A) Alignment ofWNV ectoMwith YFV and YFV17D ectoM. Blue boxes represent identical amino-
acids, red boxes represent different amino acids that were substitutedwithinWNV ectoMwith YFV residues. Asterisk pinpoints the only amino acidmutation that abrogates interaction of
WNV ectoMwith Tctex-1 (see B). (B) Amutant ofWNV ectoM inwhich residue 5 was replacedwith a proline (ectoMWNVQ5P)was generated by site-directedmutagenesis. HEK-293T
cells were co-transfected with 2 μg of a plasmid encoding the ectoM of WNV, WNV Q5P fused to GST or GST alone and 2 μg of a plasmid encoding Tctex-1 fused to 3xFLAG. 48 h post-
transfection, cellswere harvested andGSTpull-down experimentswere performed. Expression of both fusionproteinswasdetected byWesternblot using antibodies directed against GST
(panel A) and 3xFLAG (panel B). The presence of 3xFLAG-Tctex-1 after pull-down was then detected (panel C). (C) The ectoM of 4 other ﬂaviviruses containing a proline as residue 5
(Kyasanur Forest disease virus:KFDV, Tick-borneencephalitis virus: TBEV andOmskhemorrhagic fever virus:OHFV) ornot (Usutuvirus:USUV)werealso tested for their ability to interact
with Tctex-1. Redboxpinpoints residue 5. (D)HEK-293T cellswere co-transfectedwith2 μgof a plasmid encoding the ectoMofKFDV,USUVTBEV,OHFV fused toGSTorGST alone and2 μg
of a plasmid encoding Tctex-1 fused to 3xFLAG. 48 h post-transfection, cells were harvested and GST pull-down experiments were performed. Expression of both fusion proteins was
detected by Western blot using antibodies directed against GST (panel A) and 3xFLAG (panel B). The presence of 3xFLAG-Tctex-1 after pull-down was then detected (panel C).
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cells assemble and secrete recombinant subviral particles (RSPs)
undergoing maturation and trafﬁcking processes similar to that of
viral particles (Wang et al., 2009). To control Tctex-1 silencing
efﬁciency, HEK-293T cells were co-transfected with a plasmid
encoding Tctex-1 fused to 3xFLAG and NT or Tctex-1 siRNA. Tctex-1
expression was then observed by immunoblot assay using an
antibody directed against the 3xFLAG tag (Fig. 5A). Compared to
cells treated with NT siRNA (Fig. 5A, lane 1), cells treated with Tctex-1
siRNA (Fig. 5A, lane 2) show a signiﬁcant reduction in 3xFLAG-Tctex-1
expression, conﬁrming the efﬁciency of the siRNA. Hela prM-E cells
were treated either with two increasing concentrations of NT or
Tctex-1 siRNA. Cells were washed 24 h post-treatment to remove
RSPs secreted during the treatment and incubated in fresh medium
over-night. Supernatants were then collected and cells harvested. RSP
expression and release were assessed bymeasuring E and prM protein
expression in cell lysates and supernatants (Fig. 5B). Compared to
cells transfected with NT siRNA, cells transfected with Tctex-1 siRNA
show a reduction of E protein expression in supernatant (Fig. 5B,
upper panel, lanes 3 and 4 compared to lanes 1 and 2), suggesting an
inhibition of RSP secretion after Tctex-1 silencing. Compared to cellstreated with NT siRNA, intracellular expression of E protein is also
reduced after treatment with Tctex-1 siRNA (Fig. 5B, upper panel,
lanes 7 and 8 compared to lanes 5 and 6). We can see the same effect
on prM intracellular expression (Fig. 5B, lower panel, lanes 7 and
8 compared to lanes 5 and 6). The signal corresponding to prM
disappears in supernatant, indicating an efﬁcient cleavage of the
protein before secretion of the particles (Fig. 5B, lower panel, lanes 1–
4). These observations indicate that Tctex-1 is involved in DENV RSP
production. To verify whether the Tctex-1 role in RSP production is
related to its microtubule-dependent retrograde transport function
within the dynein motor complex, we tested the impact of
microtubule disruption on RSP production and release. Hela prM-E
cells were treated with nocodazole (NZ), a drug that interferes with
polymerization of microtubules. We observed a striking dismantling
of the microtubule network in NZ-treated cells compared to mock-
treated ones (Fig. 5C). RSP expression and release were then assessed
after drug treatment by measuring the expression of the E protein in
cell lysate and supernatant respectively (Fig. 5D). Despitemicrotubule
destruction in NZ-treated cells, no difference was observed in E
protein expression compared to mock-treated cells both in superna-
tant (Fig. 5D, lane 2 compared to lane 1) and cell lysate (Fig. 5D, lane 4
Fig. 3. Subcellular localization of Tctex-1 and prM proteins in DENV-infected cells. HEK-293A cells were infected at a MOI of 1 with DENV4 63632/76 Burma for 24 h. Cells were
washed with PBS and ﬁxed with 3.2% paraformaldehyde PBS. DENV prM and Tctex-1 protein were stained with 14E9 mAb and anti-Tctex-1 rabbit polyclonal antiserum R5205
respectively. Arrowheads point towards DENV-infected cells. Bottom panel represents magniﬁcation of framed cells in the upper panel. Pictures were taken using a Leica scanning
confocal SP5 microscope in sequential acquisition mode.
373J.-B. Brault et al. / Virology 417 (2011) 369–378compared to lane 3), indicating that microtubules are not involved in
the production of RSPs. Altogether these results suggest that Tctex-1
plays a role in the production of DENV particles within the infected
cells, in a way that is independent of microtubules and thus not
related to microtubule-dependent retrograde transport of the dynein
motor complex.
Discussion
Our study describes for the ﬁrst time the identiﬁcation of a host
factor interacting with the membrane protein of several ﬂaviviruses.
We showed that Tctex-1 is important for DENV and WNV infection
and is involved in the late steps of viral infection. We propose that
these viruses have the ability to highjack Tctex-1 late in their life cycle
via an interaction with the ectodomain of the M protein. The
identiﬁcation of novel host factors that ﬂaviviruses hijack and use
during infection is mandatory for a better comprehension of their
pathogenicity. No vaccine or effective antiviral molecules are
currently available to prevent or treat DENV or WNV infection, so
there is an urgent need to better understand the pathogenesis of these
viral infections. Protein–protein interactions deﬁne key biochemical
and regulatory networks in the cell, but are also targets for a virus to
ensure its life cycle as viruses are obligatory parasites. In this study,
we identiﬁed Tctex-1 protein, a member of one of the 3 DLC families,
as a partner for the ectodomain of DENV, WNV and JEV membrane
protein. Our results suggest that the interaction between the ectoM
and Tctex-1 is important for the DENV and WNV life cycle in human
hepatic and kidney cells respectively and that Tctex-1 is involved in
late stages of DENV infection. The involvement of DLC in viral
transport had already been described. Indeed, Tctex-1 has been
shown to participate in the targeting of Mason-Pﬁzer monkey virus
polyprotein to its site of assembly (Vlach et al., 2008), to interact with
Herpes simplex virus type 1 capsid protein VP26 and to participate inits cytoplasmic transport along microtubules (Douglas et al., 2004). It
was also described to interact with the human Poliovirus (PV)
receptor CD155 in order to ensure efﬁcient retrograde transport of PV-
containing vesicles along microtubules (Mueller et al., 2002; Ohka
et al., 2004). Other DLC play a role in viral transport mechanisms. LC8
for example has been described as an interactor of rabies virus
phosphoprotein P (Jacob et al., 2000; Raux et al., 2000) and African
swine fever virus p54 protein (Alonso et al., 2001) and was described
as being essential for foamy virus GAG protein (Petit et al., 2003) and
bovine immunodeﬁciency virus retrograde transport mechanisms (Su
et al., 2010).
The locationwhere ectoM encounters Tctex-1 is unclear as the two
proteins are expressed in different cellular compartments, Tctex-1
and ectoM being described as cytosolic and luminal, respectively.
However, it was demonstrated recently that upon ER stress induction,
ER membrane permeability occurs and endogenous ER luminal
proteins may be released into the cytosol (Wang et al., 2011).
Interestingly, the regulation of ER membrane permeability to luminal
proteins is dependent of Bax protein, a pro-apoptotic factor that was
described to be up-regulated during WNV and Saint-Louis encepha-
litis virus (SLEV) infection (Parquet et al., 2002, 2001). This
mechanism may be involved in ER stress-induced apoptosis, possibly
through translocation of factors from the ER lumen to the cell surface
that could facilitate in yet unknown ways apoptotic signaling cascade.
Knowing that ﬂaviviruses like WNV, JEV or DENV activate the
unfolded protein response (UPR), a cellular response induced by the
stress due to accumulation of unfolded or misfolded proteins in the ER
(Ambrose and Mackenzie, 2011; Yu et al., 2006) that can lead to ER
stress-induced apoptosis (Medigeshi et al., 2007), it is possible that
ﬂaviviral proteins expressed in the ER may be in contact with the
cytoplasm because of ER stress-induced membrane permeability,
allowing them to meet with cytosolic proteins. Another hypothesis
that could explain where the ectoM and Tctex-1 interact would be the
Fig. 4. Effect of Tctex-1 knockdown on virus progeny production. HepG2 or HEK-293A
cells were transfected with 100 nM of NT or Tctex-1 siRNA. 24 h post-transfection,
HepG2 cells were infected either with DENV or YFV at a MOI of 1 and HEK-293A cells
were infected with WNV at the same MOI. 48 h post-infection, supernatants were
collected, DENV (A) and WNV (B) progeny production was measured by Focus
Immunodetection Assay, YFV (C) progeny production was measured by plaque assay.
Difference between NT and Tctex-1 siRNA treated samples is only signiﬁcant for DENV
(**P=0.0053) andWNV infected-cells (*P=0.0491) according to t-test. For each virus,
at least two distinct experiments were performed in triplicates. Values above each bar
indicate the viral titer per milliliter of supernatant.
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glycoproteins have already been described to adopt different
transmembrane conﬁgurations. It is the case of hepatitis B virus
(HBV) L envelope protein that exhibits a dual transmembrane
topology with both luminal and cytosolic orientations (Prange and
Streeck, 1995). This dual topology is regulated by a posttranslationaltranslocation process of a L protein subdomain into the ER that
involves chaperone proteins (Lambert and Prange, 2003). However,
such a mechanism has yet never been described for ﬂaviviruses.
As shown after treatment of cells expressing DENV RSPs with
siRNA directed against Tctex-1, silencing leads to the decrease of both
intracellular and extracellular expression of viral proteins. This result
is surprising because if Tctex-1 is involved in viral trafﬁcking steps,
one would expect that upon Tctex-1 knockdown, viral components
should accumulate within the cell and thus show an increase of
intracellular expression level. However, one can argue that such an
accumulation could lead to a stress of the ER resulting in degradation
of accumulated viral proteins, explaining the decrease observed for
the intracellular signal.
Tctex-1 involvement in viral particle trafﬁcking may be linked to
its ability to interact with Src family kinases (SFKs). Two different
SFKs have been shown to be involved in ﬂaviviruses maturation/
trafﬁcking mechanisms. In fact, c-Yes protein is required for
maturation of WNV particles (Hirsch et al., 2005), and c-Src protein
is important for assembly and secretion of DENV (Chu and Yang,
2007). Interestingly, Tctex-1 has been reported to interact with Fyn, a
member of the SFK family (Campbell et al., 1998). Further experi-
ments that are currently undertaken to determine whether Tctex-1
and SFK are working together during the infection may provide a
greater comprehension of ﬂavivirus infection maturation/trafﬁcking
steps. As it has already been described, microtubules seem not to be
involved in the secretion of ﬂaviviruses (Mackenzie and Westaway,
2001), since their complete disruption using nocodazole did not
decrease RSP secretion. Such result suggests that the dynein motor
complex is not engaged with Tctex-1 in the late stages of ﬂavivirus
replication. It was already shown that there is a subset of Tctex-1
protein that localizes to the Golgi apparatus and that is not associated
with the dynein intermediate chain, indicating the existence of
distinct Tctex-1 populations with different subcellular localizations
(Tai et al., 1998). Other families of DLC have been reported to have
dynein-independent functions. LC8 is known to sequester the
proapoptotic factor BimL to the dynein motor complex. After an
apoptotic stimulus, LC8 together with BimL are released from the
motor complex and translocated to Bcl-2 to antagonize its anti-
apoptotic activity (Puthalakath et al., 1999). These ﬁndings indicate
that DLCs are able to exert different functions independently and
away from their interaction with the dynein motor complex.
Finally, the fact that not all ﬂavivirus ectoMs interact with Tctex-1
raises interrogations about viral chimeras used as potential vaccines.
Chimeric viruses containing the backbone of the 17D vaccine strain of
YFV and the prM-E region of DENV or WNV will thus exhibit the
ectodomain of the M protein that interacts with Tctex-1, in the frame
of a virus whose ectoM does not interact with Tctex-1 (namely
YFV17D). This difference should be kept in mind and evaluated as
such chimeric viruses are currently tested in immunization protocols.
In conclusion, our results formally identify DLC Tctex-1 as a cellular
interactor to the M protein from DENV, JEV and WNV and suggest a
major role for this interaction in the efﬁciency of virus replication in
human cells. This ﬁnding enhances our understanding of ﬂavivirus life
cycle, since very few host proteins involved in late steps of ﬂavivirus
infection including assembly, trafﬁcking and maturation have been
identiﬁed.
Materials and methods
Cells, viruses, antibodies and reagents
HEK-293A, HEK-293T, HepG2 andVero cellswere cultured inDMEM
medium(Invitrogen) supplementedwith 10%heat-inactivated fetal calf
serum (PAA) and 1% penicillin/streptomycin at 37 °C. Hela prM-E cell
line expressing prM and E protein from DENV1 were cultured in the
samemedium supplementedwith 500 μg/ml Hygromycin B as reported
Fig. 5. The effect of Tctex-1 knockdown or microtubule disruption on DENV RSP production. (A) To control knockdown efﬁciency, HEK-293T cells were co-transfected with 2 μg of a
plasmid encoding Tctex-1 fused to 3xFLAG and 100 nM of NT or Tctex-1 siRNA. 24 h post-transfection, Tctex-1 expression level was measured by Western blot using anti-3xFLAG
antibody. (B) Hela prM-E cells expressing DENV1 recombinant subviral particles (RSP) were transfected with 100 nM and 200 nM of NT or Tctex-1 siRNA. Supernatants were
collected and cell lysates harvested. The RSP level of expression was assessed in Western blot by measuring prM and E expression in cell lysate and supernatant using 14E9 and 4G2
antibodies respectively. (C) To control microtubule disruption efﬁciency Hela prM-E cells were treated with nocodazole (NZ) or with DMSO as a negative control for 1 h and then
stained with DM1A antibody. (D) Hela prM-E cells were treated with NZ or DMSO as a negative control. RSP level of expression was measured by Western blot in cell lysate and
supernatant using 4G2 antibody.
375J.-B. Brault et al. / Virology 417 (2011) 369–378previously (Wang et al., 2009). Mosquito AP61 cells were cultured in
Leibovitz's L-15 medium (Invitrogen) supplemented with 10% heat-
inactivated fetal calf serum (PAA), 1% penicillin/streptomycin and 1%
tryptose phosphate (Eurobio) at 28 °C.
The following virus strains from the collection of the Institut Pasteur
were used to infect cells: DENV4 63632/76 Burma, WNV IS-98-ST1 and
YFV Asibi.
Anti-3xFLAG HRP-conjugated, anti-αtubulin DM1A and DM1A-
FITC conjugated monoclonal antibodies were purchased from Sigma-
Aldrich. Anti-βtubulin goat antibodies were purchased from Abcam.
Anti-GST HRP-conjugated goat antibodies were purchased from
Amersham Biosciences. Anti-Tctex-1 rabbit polyclonal antiserumR5205 was kindly provided by Stephen M. King. 4G2 is a pan-
ﬂavivirus anti-E protein murine monoclonal antibody. 14E9 is a pan-
dengue anti-prM protein murine monoclonal antibody. All the
secondary antibodies were purchased from Jackson ImmunoResearch.
Nocodazole was purchased from Sigma Aldrich.
Yeast two-hybrid screen
Our yeast two-hybrid protocol has already been described in
details (Caignard et al., 2007). Brieﬂy, pDEST32 plasmid encoding
Gal4-DB fused to ectoMs was transformed in AH109 yeast strain
(Clontech), and used to screen by mating a human spleen cDNA
376 J.-B. Brault et al. / Virology 417 (2011) 369–378library cloned in the Gal4-AD pPC86 vector (Invitrogen) and
previously established in Y187 yeast strain (Clontech). Yeast cells
were plated on a selective medium lacking histidine to select for
interaction-dependent transactivation of HIS3 reporter gene. AD-
cDNAs from [His+] colonies were ampliﬁed by PCR and sequenced to
identify the host proteins interacting with ectoM.
Construction of expression plasmids and transfection
All constructs were ampliﬁed using standard PCRmethods (ExTaq,
Takara) and cloned using a recombinational system (Gateway,
Invitrogen) into pDONR207 (Invitrogen). PCR primers were used to
amplify and clone viral or cellular ORF displayed from 20 to 30 speciﬁc
nucleotides matching ORF extremities so that their Tm is close to
60 °C. To achieve recombinational cloning of PCR products, 5′ ends of
forward primers were fused to attB1.1 recombination sequence 5′-
GGGGACAACTTTGTACAAAAAAGTTGGCATG-3′, while reverse primers
were fused to attB2.1 recombination sequence 5′-GGGGACAACTTTG-
TACAAGAAAGTTGGTTA-3′. Primer pairs were designed using the
ViralOrfeome interface (http://www.viralorfeome.com; Pellet et al.,
2010). Recombination of PCR products into pDONR207was performed
following manufacturer's recommendation (BP cloning reaction, Invi-
trogen). All constructswere transformedandampliﬁed inEscherichia coli
DH5α strain. Subsequently, viral ectoM and Tctex-1 sequences previ-
ously cloned into pDONR207 were transferred by recombinational
reaction intoGateway compatibleGST-fusion (pDEST27, Invitrogen) and
3xFLAG-fusion (pCI-neo-3xFLAG, Mendoza et al., 2006) destination
vector respectively, following the manufacturer's recommendation (LR
cloning reaction, Invitrogen). EctoM were ampliﬁed by PCR from viral
preparations: DENV1 strain FGA/89 (Genbank ID: AF226687), DENV2
strain Jamaica/N.1409 (Genbank ID: M20558), DENV3 isolate
D3/H/IMTSSA-SRI/2000/1266 (Genbank ID:AY099336),DENV4 strain
Singapore 8976/95 (Genbank ID: AY762085), WNV strain NY99
ﬂamingo 383–99 (Genbank ID: AF196835), JEV strain SA(V) (Genbank
ID:D90194) andYFVstrain 17D(Genbank ID: X03700). YFVAsibi ectoM
was ampliﬁed from YFV strain 17D by site-directed mutagenesis
allowing the transversion mutation of nucleotide 856 from C to A.
EctoMs of USUV strain Vienna 2001 (Genbank ID: AY453411), KFDV
variant Alkhurma (Genbank ID: NC_004355), OHFV (Genbank ID:
NC_005062) and TBEV strain Neudoerﬂ (Genbank ID: U27495) as
well as mutants of WNV ectoM were synthetic genes purchased from
Genecust. Transfection was performed with Lipofectamine 2000
(Invitrogen) according to the manufacturer's recommendation.
GST pull-down
One day before transfection HEK-293T cells were seeded in 6 well
plates at a density of 8.105 cells per well. Cells were transfected with
2 μg of p3xFLAG-Tctex-1 and 2 μg of pGST-ectoM or pGST per well.
Cell layers were then harvested 48 h post-transfection using 300 μl of
lysis buffer (0.5% NP-40, 20 mM Tris–HCl pH=8, 120 mM NaCl and
1 mMEDTA) supplementedwith Complete Protease Inhibitor Cocktail
(Roche) per well. Lysates were incubated for 20 min at 4 °C and
clariﬁed by centrifugation. Lysates were then incubated with 20 μl of
glutathione-sepharose beads (Amersham Biosciences) for 2 h at 4 °C
and washed three times with 500 μl of ice-cold lysis buffer. Proteins
were recovered by boiling in Nupage LDS sample buffer (Invitrogen)
for 5 min at 95 °C.
Western blotting
Samples were separated on 4–12% Bis–Tris Gels (Invitrogen) and
transferred on nitrocellulose membranes (Hybond-ECL, Amersham
Biosciences). Membranes were blocked with 0.1% Tween 20, 5% milk
PBS overnight at 4 °C and incubated with primary antibodies: anti-GST
HRP conjugated (1:1000), anti-3xFLAG HRP conjugated (1:1000), anti-Tctex-1 rabbit polyclonal antiserum R5205 (1:100) or anti-αtubulin
DM1A (1:1000) and when necessary with HRP conjugated donkey
secondary antibodies (1:10000) for 1 h at 4 °C in 0.1% Tween 20 PBS.
Membranes were then revealed using ECL Plus Western Blotting
Detection System and Hyperﬁlm ECL (Amersham Biosciences) accord-
ing to manufacturer's recommended procedure.
Immunoﬂuorescence
Cells were ﬁxed in 3.2% paraformaldehyde (PFA) PBS for 15 min at
room temperature. Cells were then washed three times in PBS and
incubated in 50 mM NH4Cl PBS for 15 min at room temperature to
quench remaining PFA. Cells were washed three times in PBS and
permeabilized in 0.1% Triton X-100 PBS for 5 min at room temper-
ature. Cells were then washed three times in PBS and blocked with 2%
bovine serum albumin (Sigma Aldrich) PBS for 30 min at room
temperature. Cells were washed three times in PBS and incubated
with anti-Tctex-1 rabbit polyclonal antiserum R5205 (1:50) and 14E9
mAb (1:200) in 0.1% Triton X-100 PBS for 1 h at room temperature.
Cells were washed three times in PBS and were then incubated with
goat anti-rabbit Alexa Fluor 546-conjugated (1:200) and donkey anti-
mouse FITC-conjugated (1:200) secondary antibodies in 0.1% Triton
X-100 PBS for 1 h at room temperature. Cells werewashed three times
in PBS and one time in a large volume of water to remove remaining
salts. Samples were mounted in ProLong Gold antifade reagent with
DAPI (Invitrogen).
Infection
One day before infection, cells were seeded in 24 well plates. Prior
to infection cell layers were washed three times with DMEM without
FCS. Virus solutions were prepared in DMEM supplemented with 2%
of FCS at the required multiplicity of infection (MOI). 400 μl of the
viral solution were used for each well and cells were incubated for 1 h
30 min at 37 °C. The inoculum was then discarded and replaced with
500 μl of 2% FCS DMEM and cells were incubated at 37 °C for 24 h or
48 h.
RNA interference
Non-targeting (NT) and anti-Tctex-1 mRNA (5′-CCAGUGGACCA-
CAAAUGUATT-3′) siRNA duplexes were purchased from GeneCust.
Reverse transfection protocol using Dharmafect 1 transfection
medium (Dharmacon) was applied with 100 nM and 200 nM of
siRNA. Mixtures of siRNA and transfection medium were made in
DMEM and 200 μl were loaded in 24 well plates. 800 μl Hela prM-E
(105 cells/ml), HepG2 or HEK-293A (2.105 cells/ml) in 2% FCS DMEM
were added to each well and cells were incubated for 24 h at 37 °C.
Nocodazole treatment
One day before drug treatment Hela prM-E cells were seeded in 24
well plates at a density of 8.104 cells per well. Cell layers were washed
once with 2% FCS DMEM and the same medium containing 2 μg/mL
nocodazole was added. Cells were incubated for 1 h at 37 °C.
To control nocodazole efﬁciency, cells were ﬁxed in ice-cold
methanol and stained with DM1A FITC-conjugated (1:200) antibodies.
DENV RSP production and quantiﬁcation
Hela prM-E cells were treated with siRNA or nocodazole. 24 h post
siRNA transfection or 1 h post nocodazole treatment, Hela prM-E cells
were washed three times with DMEM to remove all the RSP from the
supernatant. 300 μl of 2% FCS DMEM was added to each well. SiRNA
treated cells were incubated at 37 °C overnight. Nocodazole treated
cells were incubated at 37 °C for 5 h. Supernatants were collected and
377J.-B. Brault et al. / Virology 417 (2011) 369–378cell layers harvested with 100 μl of lysis buffer. Quantiﬁcation of RSP
in cell lysates and supernatants was performed by Western blot (see
Western blotting section above).
Virus titration
DENV and WNV were titrated by focus immunodetection assay
(FIA). One day before titration, AP61 cells were seeded in 24well plates.
One day after seeding, 10 fold serial dilutions of infectious supernatants
in 10% FCS L-15mediumweremade from10−1 to 10−5 forDENVand to
10−6 for WNV. Cells were washed three times with L-15 medium
without FCS and 200 μl of 2% FCS L-15were added to eachwell. 200 μl of
dilutions 10−2 to 10−5 for DENV and 10−3 to 10−6 forWNVwere then
added and cells were incubated for 2 h at 28 °C. In the meantime, a 1:1
solution of carboxy-methyl cellulose (CMC) and 10% FCS L-15 was
prepared and 400 μl were added to each well. Cells infected with DENV
were incubated for 5 days, cells infected with WNV for 3 days at 28 °C.
Cellswere thenwashed three times inPBS andﬁxed in 3% formaldehyde
PBS for 20 min at room temperature. Cells were washed three times
with PBS and permeabilized with 0.1% Triton X-100 PBS for 4 min at
room temperature, washed three times with PBS and incubated with
4G2 antibodies for 30 min at 37 °C. Cells were washed three times with
PBS and incubated with anti-mouse HRP-conjugated antibodies for 1 h
at 37 °C. Foci were then revealed using diaminobenzidine (Sigma)
(previously described in Despres et al., 1993).
YFV was titrated by plaque assay. One day before titration, Vero
cells were seeded in 24 well plates. One day after seeding, 10 fold
serial dilutions of infected supernatants in 2% FCS DMEM from 10−1
to 10−6 were prepared. Cells were washed three times with DMEM
without FCS and 200 μl of 2% FCS DMEM were added to each well.
200 μl of dilutions 10−3 to 10−6 were then added and cells were
incubated for 2 h at 37 °C. In the meantime, a 1:1 solution of CMC and
4% FCS DMEM was made and 400 μl were added to each well. Cells
were then incubated at 37 °C for 5 days. Cells were washed three
times in PBS and colored with 3% formaldehyde crystal violet for
20 min at room temperature. Cells were washed with water and
plaques were counted.
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